의료용 자외선 소독 장비 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the healthcare UV disinfection equipment market is expected to increase from USD 1.19 billion in 2025 to USD 1.31 billion in 2026 and reach USD 2.31 billion by 2031, growing at a CAGR of 12.05% over 2026-2031.

This report is Segmented by Product Type (UV-C Robots, Fixed UV-C Systems, and More), Technology (Low-Pressure Mercury Lamp-Based Systems, Pulsed Xenon, and More), Application (Patient Room Disinfection, and More), End-User (Hospitals, Ambulatory Surgical Centers, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Healthcare UV Disinfection Equipment Market Trends and Insights

Rising Healthcare-Associated Infection Pressure in High-Acuity Care

The healthcare UV disinfection equipment market continues to draw its strongest support from the persistence of healthcare-associated infections in hospital settings. The CDC's 2024 national report, published in January 2026, showed a 11% decline in hospital-onset C. difficile and a 7% decline in MRSA bacteremia versus 2023, which confirms that infection control remains a central operating priority for providers. The same report also showed that abdominal hysterectomy surgical site infections increased 8% in 2024, which suggests that important gaps remain despite broader progress in other infection categories. Global infection pressure remains large as industry association data cited a WHO estimate that 10% of hospitalized patients acquire a healthcare-associated infection, while antimicrobial resistance is linked to 136 million related cases each year. In this setting, the healthcare UV disinfection equipment market benefits because UV-C systems address pathogens without adding chemical residue or antimicrobial resistance pressure. That is why purchasing teams increasingly view these devices as part of baseline infection control capacity rather than as an optional add-on.

Shift Toward Continuous, Chemical-Free Disinfection in Occupied Spaces

The healthcare UV disinfection equipment market is also gaining from the move away from periodic room shutdowns toward continuous germ control in occupied spaces. A 2025 study in Infection Control & Hospital Epidemiology found that ceiling-mounted far-UVC fixtures reduced surface bioburden in occupied clinical areas even during routine staff and patient activity. The healthcare UV disinfection equipment market therefore has room to grow in wards, laboratories, and care areas where steady occupancy makes manual disinfection harder to repeat at the needed frequency. A 2025 installation in a Swedish palliative care ward also reported staff sick leave of 0.4% compared with a regional average near 6%, which is helping far-UVC enter more operational conversations beyond intensive care settings.

Line-of-Sight Limitations that Reduce Efficacy in Cluttered Clinical Rooms

The healthcare UV disinfection equipment market still faces a basic performance challenge in rooms with dense equipment and irregular surfaces. Intensive care units, operating rooms, and medication spaces often create shadowed areas that receive a weaker dose than exposed surfaces. The healthcare UV disinfection equipment market therefore still depends on multi-position cycles, added emitters, or better room mapping to close the gap between dose delivery and real-world room geometry. Until those features become more consistent across products, hospitals will continue to scrutinize claims around whole-room effectiveness.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of UV-C Use Beyond Terminal Cleaning into Air, Surfaces, and Devices
2. Declining UV-C LED Costs and Improved Energy Efficiency
3. High Capex and Service Burden for Hospital-Grade Systems

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

UV-C robots held 46.38% of the product type segment in 2025, which made them the largest category in the healthcare UV disinfection equipment market. Their position reflects strong adoption in high-acuity facilities that want autonomous, dose-verified room disinfection with limited dependence on manual technique. Hospitals also favor these systems where patient turnover is high and infection prevention teams need repeatable workflows. The healthcare UV disinfection equipment industry therefore treats robotic platforms as the core reference category for large-site procurement.

Handheld UV-C devices are forecasted to grow at 12.62% CAGR through 2031, which makes them the fastest-rising product format in the healthcare UV disinfection equipment market. A 2025 genomic analysis also reported mean colony-forming unit reductions of 53% to 83% across armchairs, keyboards, and workroom surfaces with a far-UVC handheld device. Their flexibility matters because staff can target shadowed or irregular surfaces that room robots may not fully address. That makes handheld tools a complement to robots instead of a simple low-cost substitute.

Low-pressure mercury lamp-based systems retained 49.72% of the technology segment in 2025, which means they still represented the largest installed technology base in the healthcare UV disinfection equipment market. Their position reflects long-standing use in hospital UV-C deployments and familiar germicidal performance at 254 nm. These systems remain embedded in procurement cycles because many facilities already understand their operating profile and replacement needs. The healthcare UV disinfection equipment market therefore still carries a large installed-base effect that favors existing mercury platforms in the near term.

UV-C LED systems are projected to grow at 14.18% CAGR through 2031, which makes them the fastest-growing technology in the healthcare UV disinfection equipment market. Far-UVC systems at 222 nm add another layer of change because they can be used in occupied spaces under clinical conditions now being tested more widely. As a result, the technology shift is being driven by both component progress and a broader change in how facilities want to apply UV disinfection.

Complete Report Scope:

• By Product Type
  • UV-C Robots
  • Fixed UV-C Systems
  • Handheld UV-C Devices
  • UV-C Cabinets and Chambers
• By Technology
  • Low-Pressure Mercury Lamp-Based Systems
  • Pulsed Xenon Systems
  • UV-C LED Systems
  • Far-UVC Systems
• By Application
  • Patient Room Disinfection
  • Air Disinfection in Clinical Areas
  • Operating Room Sterilization
  • Medical Equipment Disinfection
• By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Long-Term Care Facilities
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 42.19% of global revenue in 2025, which gave it the largest position in the healthcare UV disinfection equipment market share by region. The region benefits from high awareness of healthcare-associated infections and stronger alignment between infection outcomes, procurement standards, and hospital operating priorities. Hospitals across the United States continue to face visible HAI reporting pressure, which helps sustain demand for validated environmental disinfection tools. Canada is also becoming more relevant in regional procurement, with Xenex receiving Health Canada registration for LightStrike6 in January 2026. Mexico and Canada offer additional room for expansion, though the U.S. remains the main revenue anchor.

Europe remains one of the core pillars of the healthcare UV disinfection equipment market because infection control awareness is high and the installed base is large. Germany, the United Kingdom, France, Italy, and Spain continue to anchor demand through broad hospital infrastructure and replacement cycles. The review of the RoHS exemption for UV-spectrum mercury lamps is pushing buyers to think earlier about mercury-free alternatives in long-term capital plans. Procurement standards also matter, with IEC 62471 and UL 8802 shaping the technical expectations around germicidal UV equipment and system safety.

Asia-Pacific is expected to be the fastest-growing regional block in the healthcare UV disinfection equipment market, with a projected CAGR of 15.31% through 2031. Growth is tied to hospital expansion, infection-control modernization, and rising interest in LED-based systems across China, India, Japan, South Korea, and Australia. Japan and South Korea are ahead in robotic adoption, while India and Southeast Asia are earlier in the uptake curve and are more likely to favor systems with lower capital intensity. The Middle East and Africa remain earlier-stage markets, although GCC hospital expansion programs are creating demand for integrated UV-C installations, and South Africa has the most advanced sub-Saharan base for adoption. South America is still developing, with Brazil and Argentina leading regional demand as private hospital investment gradually improves access to these technologies.

1. Aereus Technologies Inc.
2. American Ultraviolet
3. Aqua Ultraviolet
4. Aquionics
5. Atlantic Ultraviolet
6. Bioquell Group
7. Crystal IS, Inc.
8. Ecolab
9. Finsen Technologies
10. Halma
11. Lumalier Corporation
12. Signify N.V.
13. Skytron
14. Steriliz LLC
15. STERIS
16. Trojan Technologies
17. Tru-D SmartUVC
18. UltraViolet Devices
19. UVD Robots
20. Xenex Disinfection Services, Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Healthcare-Associated Infection Pressure in High-Acuity Care
  • 4.2.2 Shift Toward Continuous, Chemical-Free Disinfection in Occupied Spaces
  • 4.2.3 Expansion of UV-C Use Beyond Terminal Cleaning into Air, Surfaces, and Devices
  • 4.2.4 Retrofit Demand from HVAC and Upper-Air Infection-Control Upgrades
  • 4.2.5 Declining UV-C LED Costs and Improved Energy Efficiency
  • 4.2.6 Need for Audit-Ready Disinfection Traceability in Regulated Facilities
• 4.3 Market Restraints
  • 4.3.1 Line-of-Sight Limitations that Reduce Efficacy in Cluttered Clinical Rooms
  • 4.3.2 Safety, Certification, and Operator Exposure Constraints
  • 4.3.3 High Capex and Service Burden for Hospital-Grade Systems
  • 4.3.4 Supply Concentration in Deep-UV Components and Replacement Parts
• 4.4 Supply/Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product Type
  • 5.1.1 UV-C Robots
  • 5.1.2 Fixed UV-C Systems
  • 5.1.3 Handheld UV-C Devices
  • 5.1.4 UV-C Cabinets and Chambers
• 5.2 By Technology
  • 5.2.1 Low-Pressure Mercury Lamp-Based Systems
  • 5.2.2 Pulsed Xenon Systems
  • 5.2.3 UV-C LED Systems
  • 5.2.4 Far-UVC Systems
• 5.3 By Application
  • 5.3.1 Patient Room Disinfection
  • 5.3.2 Air Disinfection in Clinical Areas
  • 5.3.3 Operating Room Sterilization
  • 5.3.4 Medical Equipment Disinfection
• 5.4 By End-User
  • 5.4.1 Hospitals
  • 5.4.2 Ambulatory Surgical Centers
  • 5.4.3 Diagnostic Laboratories
  • 5.4.4 Long-Term Care Facilities
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, Recent Developments)
  • 6.3.1 Aereus Technologies Inc.
  • 6.3.2 American Ultraviolet
  • 6.3.3 Aqua Ultraviolet
  • 6.3.4 Aquionics
  • 6.3.5 Atlantic Ultraviolet Corporation
  • 6.3.6 Bioquell Group
  • 6.3.7 Crystal IS, Inc.
  • 6.3.8 Ecolab Inc.
  • 6.3.9 Finsen Technologies
  • 6.3.10 Halma plc
  • 6.3.11 Lumalier Corporation
  • 6.3.12 Signify N.V.
  • 6.3.13 Skytron, LLC
  • 6.3.14 Steriliz LLC
  • 6.3.15 STERIS plc
  • 6.3.16 Trojan Technologies
  • 6.3.17 Tru-D SmartUVC
  • 6.3.18 UltraViolet Devices, Inc.
  • 6.3.19 UVD Robots
  • 6.3.20 Xenex Disinfection Services, Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment